Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Total Non-Current Liabilities (2016 - 2025)

Abeona Therapeutics has reported Total Non-Current Liabilities over the past 11 years, most recently at $41.5 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $41.5 million for Q4 2025, up 26.05% from a year ago — trailing twelve months through Dec 2025 was $41.5 million (up 26.05% YoY), and the annual figure for FY2025 was $41.5 million, up 26.05%.
  • Total Non-Current Liabilities for Q4 2025 was $41.5 million at Abeona Therapeutics, up from $37.3 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for ABEO hit a ceiling of $82.7 million in Q1 2024 and a floor of $16.9 million in Q3 2023.
  • Median Total Non-Current Liabilities over the past 5 years was $28.2 million (2021), compared with a mean of $35.4 million.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 380.47% in 2024 and later crashed 59.86% in 2025.
  • Abeona Therapeutics' Total Non-Current Liabilities stood at $28.2 million in 2021, then crashed by 36.92% to $17.8 million in 2022, then rose by 0.16% to $17.8 million in 2023, then surged by 84.5% to $32.9 million in 2024, then rose by 26.05% to $41.5 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $41.5 million (Q4 2025), $37.3 million (Q3 2025), and $52.5 million (Q2 2025) per Business Quant data.